Advertisement
UK markets open in 7 hours 10 minutes
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • CRUDE OIL

    82.83
    +0.02 (+0.02%)
     
  • GOLD FUTURES

    2,328.10
    -10.30 (-0.44%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • Bitcoin GBP

    51,577.56
    -1,716.70 (-3.22%)
     
  • CMC Crypto 200

    1,384.86
    -39.25 (-2.76%)
     
  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

Wall Street Is Bullish on Nektar Stock despite Stock Price Slump

Wall Street Is Bullish on Nektar Stock despite Stock Price Slump

Does Nektar's Stock Price Correction Signal a Good Opportunity? Nektar Therapeutics (NKTR) is a development-stage biotechnology company that has a drug pipeline focused on the treatment of cancer, autoimmune diseases, and chronic pain. The company has entered a number of key collaborations recently to advance its drug pipeline.